PTGX
NASDAQ HealthcareProtagonist Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $95.42 |
|---|---|
| Volume | 742,311 |
| Market Cap | 6.09B |
| Beta | 2.240 |
| RSI (14-Day) | 71.7 Overbought |
| 200-Day MA | $71.28 |
| 50-Day MA | $85.64 |
| 52-Week High | $98.32 |
| 52-Week Low | $39.60 |
| Forward P/E | -163.18 |
| Price / Book | 9.71 |
🎯 Investment Strategy Scores
How PTGX scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
3/100
High dividend yield + low volatility
🚀 Moon Shot
80/100
High growth potential (high beta + oversold)
🔪 Falling Knife
4/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
95/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
64/100
Large-cap, institutional-quality stocks
Find PTGX in your text
Paste any text on the homepage — the tool will extract PTGX and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.